NeuPath Health to Participate in the Annual SmallCap Discoveries Conference in Vancouver, Showcasing Leadership in Chronic Pain Treatment
NeuPath Health Inc. (TSXV: NPTH) (“NeuPath” or the “Company”), a leading owner and operator of a network of specialized clinics focused on delivering innovative, category-leading chronic pain treatment, is pleased to announce its participation in the upcoming Annual SmallCap Discoveries Conference, set to take place in Vancouver, British Columbia, on September 29-30, 2025.
The Annual SmallCap Discoveries Conference is widely recognized as one of Canada’s premier investor events, designed to connect emerging growth companies with an engaged community of investors, analysts, and industry leaders. NeuPath’s presence at the conference underscores its commitment to sharing its vision, strategic initiatives, and growth plans with the investment community, while highlighting its ongoing contributions to the evolving landscape of chronic pain management.
NeuPath Health has confirmed that Joe Walewicz, Chief Executive Officer, and Stephen Lemieux, President, will deliver a detailed presentation on Monday, September 29, 2025, from 9:30 a.m. to 10:00 a.m. PT in Room D at the Parq Hotel and Casino. During this session, attendees can expect an in-depth overview of NeuPath’s recent achievements, ongoing operational initiatives, and its strategic roadmap for the future. The presentation will provide valuable insight into how the company is leveraging its expertise, innovative clinical methodologies, and patient-centric model to strengthen its position within the chronic pain treatment sector.
NeuPath Health: Pioneering Chronic Pain Treatment
NeuPath Health has rapidly established itself as a leader in chronic pain management by offering evidence-based, patient-focused care through its growing network of clinics. Chronic pain is a widespread and often debilitating condition that affects millions of Canadians and poses significant challenges for healthcare systems worldwide. NeuPath’s clinics are strategically designed to deliver integrated treatment solutions that combine clinical excellence with personalized patient care, allowing individuals to achieve meaningful improvements in their quality of life.
The company’s approach to chronic pain treatment emphasizes a combination of advanced therapies, multidisciplinary collaboration, and patient education. By providing tailored treatment plans and leveraging innovative medical technologies, NeuPath helps patients manage their pain more effectively, reduce reliance on medications, and regain control over their daily lives. This patient-first philosophy has positioned the company as a trusted name in the industry and as a model for the future of chronic pain management clinics.
The Importance of the SmallCap Discoveries Conference
The Annual SmallCap Discoveries Conference serves as a vital platform for Canadian microcap and small-cap companies to engage with the investment community in a focused and impactful way. Unlike larger industry conferences that may cater to multinational corporations or high-profile companies, SmallCap Discoveries emphasizes emerging growth businesses that are often underrepresented in mainstream capital markets. By providing a curated environment for presentations, keynote sessions, and one-on-one meetings, the conference enables companies like NeuPath to connect directly with potential investors, industry analysts, and strategic partners.
This year’s Vancouver conference is scheduled over two days, September 29-30, at the Parq Hotel and Casino, a central and accessible location that facilitates networking and collaboration. The event brings together a diverse array of participants, including public company executives, institutional and retail investors, analysts, and service providers. By fostering dialogue and interaction between these stakeholders, the conference helps strengthen Canada’s microcap ecosystem, enhances access to capital, and supports long-term growth opportunities for emerging businesses.
NeuPath’s Participation and Investor Engagement
NeuPath Health’s participation in the SmallCap Discoveries Conference highlights the company’s proactive approach to investor relations and corporate transparency. CEO Joe Walewicz and President Stephen Lemieux are expected to provide a comprehensive overview of the company’s operations, discuss strategic growth initiatives, and answer questions from attendees. Topics likely to be addressed include recent clinic expansions, adoption of new clinical technologies, innovations in patient care, and ongoing efforts to improve operational efficiency across the company’s network.
Investors interested in meeting directly with NeuPath during the conference are encouraged to schedule one-on-one sessions by contacting the conference coordinator at trevor@smallcapdiscoveries.com. These private meetings provide an opportunity to engage in detailed discussions about the company’s financial performance, growth prospects, and long-term strategic vision. By facilitating direct dialogue between company executives and the investor community, NeuPath is able to foster greater understanding of its business model and reinforce investor confidence in its growth trajectory.
Supporting Canada’s Microcap and Growth Companies
The SmallCap Discoveries Conference is more than just a networking event—it is a community-driven initiative designed to create a healthier environment for capital formation, innovation, and entrepreneurship in Canada. Microcap and small-cap companies often face challenges in gaining visibility among investors due to limited marketing resources and the highly competitive nature of financial markets. Events like this conference play a critical role in bridging that gap by offering companies a platform to showcase their potential and secure the support needed to expand operations, innovate, and contribute to the broader economy.
By participating in this conference, NeuPath is not only advancing its corporate objectives but also contributing to a larger effort to strengthen the Canadian growth company ecosystem. The event emphasizes long-term value creation by promoting meaningful engagement between companies and investors, fostering transparency, and encouraging innovation within emerging sectors of the economy.
Looking Ahead: NeuPath’s Strategic Vision
As NeuPath Health continues to expand its network of chronic pain treatment clinics across Canada, participation in high-profile investor events like the SmallCap Discoveries Conference plays a pivotal role in achieving the company’s strategic objectives. NeuPath is focused on sustainable growth, operational excellence, and clinical innovation, all of which are central to its mission of delivering exceptional patient outcomes.
In addition to highlighting recent accomplishments, the upcoming presentation will provide attendees with insight into the company’s future initiatives, including planned clinic expansions, adoption of cutting-edge therapies, and ongoing efforts to optimize the patient experience. By sharing this vision with the investment community, NeuPath seeks to attract long-term support, build strategic partnerships, and reinforce its position as a leader in the chronic pain treatment sector.
Conference Registration and Attendance
Investors, analysts, and other interested parties are invited to attend the Annual SmallCap Discoveries Conference in Vancouver to experience the presentations, keynote sessions, and networking opportunities firsthand. Registration for a conference pass is available online, providing access to all sessions, exhibitions, and curated one-on-one meetings with participating companies. Attendees can learn more about NeuPath Health’s operations, interact directly with executive leadership, and gain a deeper understanding of the company’s growth strategy and value proposition.
